Skip to content

South Africa: authorities rush to control illegal medicines boom

HIV-positive patients have increased risk of side-effects to key drugs used to treat opportunistic infections

Recombinant human growth hormone reduces visceral fat in two randomised studies

Medication errors common among hospitalised HIV patients

Genetic marker predicts liver harm from nevirapine or efavirenz

Final results confirm twice-daily boosted fosamprenavir is comparable to twice-daily Kaletra in treatment-naive

Micronutrient supplement increases CD4 cell counts in patients on antiretroviral therapy

Kaletra monotherapy as effective as triple therapy for at least 18 months

Kaletra monotherapy - more encouraging results